Blood glucose trajectories and incidence of diabetes mellitus in Ugandan people living with HIV initiated on dolutegravir.
第一作者:
Frank,Mulindwa
第一单位:
Capacity Building Program, Makerere University Infectious Diseases Institute, Kampala, Uganda. fmulindwa@idi.co.ug.;Global Health Institute, Antwerp University, Antwerp, Belgium. fmulindwa@idi.co.ug.
作者:
医学主题词
HIV整合酶抑制剂(HIV Integrase Inhibitors);杂环化合物, 3环(Heterocyclic Compounds, 3-Ring);人类(Humans);发病率(Incidence);血糖自我监测(Blood Glucose Self-Monitoring);HIV感染(HIV Infections);血糖(Blood Glucose);糖尿病, 2型(Diabetes Mellitus, Type 2)
DOI
10.1186/s12981-023-00510-6
PMID
36915103
发布时间
2026-01-27
基金项目
D43 TW009343/TW/FIC NIH HHS/United States
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



